PHETA1: A Potential Drug Target and Biomarker (G144717)

Target Name: PHETA1

NCBI ID: G144717

PHETA1

PHETA1: A Potential Drug Target and Biomarker

PHETA1, also known as PH domain-containing endocytic trafficking adaptor 1, is a protein that plays a crucial role in the regulation of endocytosis, a process by which cells engulf and internalize external molecules such as drugs, toxins, and nutrients. Discovered in 2005, PHETA1 has been shown to be involved in the regulation of endocytosis by affecting the trafficking of various cell types, including neurons and immune cells.

Endocytosis is a complex process that involves several steps, including the internalization of the vesicle, the subsequent fusion of the vesicle with the endosome, and the final release of the contents into the cytosol. The regulation of endocytosis is essential for the proper functioning of cells, as it allows them to efficiently internalize substances that are essential for survival.

PHETA1 is a protein that is primarily localized to the endosome, a specialized organelle that is responsible for the internalization of vesicles. It is composed of 110 amino acids and has a molecular weight of 13.9 kDa. PHETA1 is localized to the endosome by its ability to interact with the transmembrane protein, known as PSIP, which is also known as tyrosine-protein kinase (TPK).

PHETA1 has been shown to play a role in the regulation of endocytosis in various cell types, including neurons and immune cells. For example, studies have shown that PHETA1 promotes the internalization of the neurotransmitter dopamine in neurons, which is known to play a crucial role in the regulation of various cellular processes, including movement, emotion, and memory.

Additionally, PHETA1 has also been shown to be involved in the regulation of endocytosis in cancer cells. For instance, studies have shown that PHETA1 is associated with the development and progression of various cancers, including breast, ovarian, and prostate cancers. This suggests that PHETA1 may be a potential drug target for cancer treatment.

In conclusion, PHETA1 is a protein that is involved in the regulation of endocytosis, a process that is essential for the proper functioning of cells. Its role in this process has been studied extensively, and its potential as a drug target or biomarker is being investigated. Further research is needed to fully understand the function of PHETA1 and its potential as a therapeutic approach.

Protein Name: PH Domain Containing Endocytic Trafficking Adaptor 1

Functions: Plays a role in endocytic trafficking. Required for receptor recycling from endosomes, both to the trans-Golgi network and the plasma membrane

The "PHETA1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PHETA1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets